Risedronic acid ≥97 %|CAS:105462-24-6|25 mg|100 mg|250 mg

Risedronate|Risedronic acid is a bisphosphonate clinically used to strengthen bone; it exhibits anti-osteoporotic, anti-inflammatory, antinociceptive, and antibiotic activities. Risedronic acid inhibits bone marrow adipogenesis and suppresses RANKL expression in vivo. In vivo, risedronic acid displays anti-malarial activity, inhibiting the transfer of farnesyl phosphate to Plasmodium proteins and preventing parasitic growth in vivo. Additionally, risedronic acid inhibits release of TNF- and leukotriene B4 (LTB4), decreasing inflammatory cell infiltration in vivo. In other animal models, risedronic acid inhibits chemically-induced pain.|C7H11NO7P2|283.11||Ambient|